Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2016 (2016), Article ID 1786265, 5 pages
http://dx.doi.org/10.1155/2016/1786265
Case Report

Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection

1Division of Infectious Diseases, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia
2Department of Nephrology, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia

Received 11 June 2016; Revised 14 August 2016; Accepted 28 August 2016

Academic Editor: Carl Classen

Copyright © 2016 Fatehi Elnour Elzein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Bisoffi, D. Buonfrate, A. Montresor et al., “Strongyloides stercoralis: a plea for action,” PLoS Neglected Tropical Diseases, vol. 7, no. 5, Article ID e2214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Mahmoud, “Strongyloidiasis,” Clinical Infectious Diseases, vol. 1, pp. 949–952, 1996. View at Google Scholar
  3. D. Robson, N. J. Beeching, and V. Gill, “Strongyloides hyperinfection syndrome in British veterans,” Annals of Tropical Medicine and Parasitology, vol. 103, no. 2, pp. 145–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Roxby, G. S. Gottlieb, and A. P. Limaye, “Strongyloidiasis in transplant patients,” Clinical Infectious Diseases, vol. 49, no. 9, pp. 1411–1423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Marcos, A. Terashima, M. Canales, and E. Gotuzzo, “Update on strongyloidiasis in the immunocompromised host,” Current Infectious Disease Reports, vol. 13, no. 1, pp. 35–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Cruz, G. Reboucas, and H. Rocha, “Fatal strongyloidiasis in patients receiving corticosteroids,” The New England Journal of Medicine, vol. 275, no. 20, pp. 1093–1096, 1966. View at Publisher · View at Google Scholar · View at Scopus
  7. B. A. Abdalhamid, A. N. A. M. Al Abadi, M. I. Al Saghier, A. A. Joudeh, M. A. Shorman, and S. S. Amr, “Strongyloides stercoralis infection in kidney transplant recipients,” Saudi Journal of Kidney Diseases and Transplantation, vol. 26, no. 1, pp. 98–102, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Mokaddas, S. Shati, A. Abdulla et al., “Fatal strongyloidiasis in three kidney recipients in Kuwait,” Medical Principles and Practice, vol. 18, no. 5, pp. 414–417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Said, M. R. N. Nampoory, M. P. Nair et al., “Hyperinfection strongyloidiasis: an anticipated outbreak in kidney transplant recipients in Kuwait,” Transplantation Proceedings, vol. 39, no. 4, pp. 1014–1015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. B. Keiser and T. B. Nutman, “Strongyloides stercoralis in the immunocompromised population,” Clinical Microbiology Reviews, vol. 17, no. 1, pp. 208–217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. A. Schad, “Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients,” The Journal of Infectious Diseases, vol. 153, no. 1, p. 178, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. Carvalho and A. Da Fonseca Porto, “Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis,” Parasite Immunology, vol. 26, no. 11-12, pp. 487–497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Y. Wang, S. Krishnan, and H. D. Isenberg, “Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy,” The Mount Sinai Journal of Medicine, vol. 66, no. 2, pp. 128–132, 1999. View at Google Scholar · View at Scopus
  14. S. Varani, G. Frascaroli, M. P. Landini, and C. Söderberg-Nauclér, “Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity,” Reviews in Medical Virology, vol. 19, no. 3, pp. 131–145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Moon, E. A. Kim, K. S. Lee, T. S. Kim, K.-J. Jung, and J.-H. Song, “Cytomegalovirus pneumonia: high-resolution CT findings in ten non-AIDS immunocompromised patients,” Korean Journal of Radiology, vol. 1, no. 2, pp. 73–78, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. T. T. Khan, F. Elzein, A. Fiaar, and F. Akhtar, “Recurrent Streptococcus bovis meningitis in Strongyloides stercoralis hyperinfection after kidney transplantation the dilemma in a non-endemic area,” The American Journal of Tropical Medicine and Hygiene, vol. 90, no. 2, pp. 312–314, 2014. View at Publisher · View at Google Scholar
  17. A. Adedeji, C. P. K. Subudhi, A. J. Hutchison, J. P. Burnie, and J. R. Kerr, “Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure,” Nephrology Dialysis Transplantation, vol. 16, no. 12, pp. 2429–2430, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Buonfrate, A. Requena-Mendez, A. Angheben et al., “Severe strongyloidiasis: a systematic review of case reports,” BMC Infectious Diseases, vol. 13, no. 1, article 78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Centers for Disease Control and Prevention, “Transmission of Strongyloides stercoralis through transplantation of solid organs—Pennsylvania, 2012,” MMWR Morbidity and Mortality Weekly Report, vol. 62, no. 14, pp. 264–266, 2013. View at Google Scholar
  20. I. Izquierdo, J. Briones, R. Lluch, C. Arqueros, and R. Martino, “Fatal Strongyloides hyperinfection complicating a gram-negative sepsis after allogeneic stem cell transplantation: a case report and review of the literature,” Case Reports in Hematology, vol. 2013, Article ID 860976, 5 pages, 2013. View at Publisher · View at Google Scholar
  21. P. Steinmann, X.-N. Zhou, Z.-W. Du et al., “Occurrence of Strongyloides stercoralis in Yunnan Province, China, and comparison of diagnostic methods,” PLoS Neglected Tropical Diseases, vol. 1, no. 1, article e75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Buonfrate, F. Formenti, F. Perandin, and Z. Bisoffi, “Novel approaches to the diagnosis of Strongyloides stercoralis infection,” Clinical Microbiology and Infection, vol. 21, no. 6, pp. 543–552, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Watts, G. Robertson, and R. S. Bradbury, The Laboratory Diagnosis of Strongyloides, vol. 1, The Australian Society for Microbiology, Canberra, Australia, 2016.
  24. P. P. Yori, M. Kosek, R. H. Gilman et al., “Seroepidemiology of strongyloidiasis in the Peruvian Amazon,” American Journal of Tropical Medicine and Hygiene, vol. 74, no. 1, pp. 97–102, 2006. View at Google Scholar · View at Scopus
  25. C. Henriquez-Camacho, E. Gotuzzo, J. Echevarria et al., “Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD007745, 2016. View at Publisher · View at Google Scholar